Starting from healthcare resource management to efficient handling of medical records and patient data, the Medical Info Systems industry is rapidly expanding its boundaries with each passing day. Banking on quickmoving technological advancements and exponentially growing worldwide demand for new-generation products, the industry has vastly improved patient care and also enhanced the network between healthcare providers and insurance plans. Added to this is the latest GenAI wave, which has significantly spe ...

Inspire Medical Systems (INSP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Individual ...

MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q3 20 ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? T ...

MINNEAPOLIS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Morgan Stanley 22nd Annual Global Healthcare Conference and the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024. Inspire is scheduled to present at the Morgan Sta ...

Inspire Medical Systems (INSP) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving. The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this maker of devices for treating obstructive sleep apnea, should get reflected in its stock price. After all, empirical research shows a strong c ...

Inspire Medical Systems, Inc. (INSP) reported earnings per share of 32 cents for the second quarter of 2024 against the Zacks Consensus Estimate of a loss of 14 cents per share. In the year-ago period, the company had incurred a loss of 41 cents per share. Revenues in Detail Inspire Medical registered revenues of $195.9 million in the second quarter, up 29.8% year over year. The figure beat the Zacks Consensus Estimate by 3.7%. Segment Details Inspire Medical's operations consist of two geographic regions — ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - Chairman and Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Richard Newitter - Truist Securities Adam Maeder - Piper Sandler Anthony Petrone - Mizuho Group Danielle Antalffy - UBS Michael Sarcone - Jefferies Chris Pasquale - Nephron Research Brett Fishbin ...

For the quarter ended June 2024, Inspire Medical Systems (INSP) reported revenue of $195.89 million, up 29.7% over the same period last year. EPS came in at $0.32, compared to -$0.41 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $195.9 million, representing a surprise of -0.01%. The company delivered an EPS surprise of +328.57%, with the consensus EPS estimate being -$0.14. While investors scrutinize revenue and earnings changes year-over-year and how they compare ...

Inspire Medical Systems (INSP) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $0.14 per share. This compares to loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 328.57%. A quarter ago, it was expected that this maker of devices for treating obstructive sleep apnea would post a loss of $0.63 per share when it actually produced a loss of $0.34, delivering a su ...